SCHEMBL29967341

SCHEMBL29967341

COc1ccc2cc(Br)ccc2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.60
CYP1A2 P05177 1/20 0.60
FLT3 P36888 1/20 0.56
HSD17B1 P14061 1/20 0.52
HSD17B2 P37059 1/20 0.52
NCEH1 Q6PIU2 1/20 0.52
LMNA P02545 2/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
KDM4E B2RXH2 2/20 0.48
GSTP1 P09211 1/20 0.48
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
MAPT P10636 2/20 0.48
ALDH1A1 P00352 1/20 0.48
NCF1 P14598 1/20 0.47
RXFP1 Q9HBX9 3/20 0.47
RAB9A P51151 2/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL227023 1.00 CYP2A6 (0.60) CYP2A6CYP1A2FLT3HSD17B1HSD17B2
SCHEMBL7529485 0.98 CYP2A6 (0.58) CYP2A6CYP1A2FLT3HSD17B1HSD17B2
Ammonia Solution, Strong SCHEMBL8045635 0.98 CYP2A6 (0.58) CYP2A6CYP1A2FLT3HSD17B1HSD17B2
Methyl Alcohol SCHEMBL29235760 0.96 FLT3 (0.57) CYP2A6CYP1A2FLT3HSD17B1HSD17B2
SCHEMBL3138744 0.96 CYP2A6 (0.61) CYP2A6CYP1A2FLT3HSD17B1HSD17B2
SCHEMBL9381604 0.90 CA12 (0.52) CYP2A6CYP1A2FLT3HSD17B1HSD17B2
SCHEMBL1758778 0.85 CYP2A6 (0.48) CYP2A6CYP1A2FLT3HSD17B1HSD17B2
SCHEMBL29447161 0.84 CYP1A2 (0.79) CYP2A6CYP1A2HSD17B1HSD17B2KDM4E
SCHEMBL443070 0.84 CYP1A2 (0.79) CYP2A6CYP1A2HSD17B1HSD17B2KDM4E
SCHEMBL1129092 0.83 HSD17B1 (0.66) CYP2A6CYP1A2HSD17B1HSD17B2GSTP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025076285-A1 COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME DELPHIA THERAPEUTICS, INC. (US) 2025-04-10 WO disclosed
EP-4065574-A1 SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIVATION Bayer Aktiengesellschaft (DE) 2022-10-05 EP disclosed